Superoxide Dismutase 1 Protects Hepatocytes from Type I Interferon-Driven Oxidative Damage.
Superoxide Dismutase 1 Protects Hepatocytes from Type I Interferon-Driven Oxidative Damage.
复制标题
DOI:
10.1016/j.immuni.2015.10.013
复制
发表时间:
2015-11-17
期刊:
影响因子:
32.4
通讯作者:
Bergthaler A
中科院分区:
文献类型:
--
作者:
Bhattacharya A;Hegazy AN;Deigendesch N;Kosack L;Cupovic J;Kandasamy RK;Hildebrandt A;Merkler D;Kühl AA;Vilagos B;Schliehe C;Panse I;Khamina K;Baazim H;Arnold I;Flatz L;Xu HC;Lang PA;Aderem A;Takaoka A;Superti-Furga G;Colinge J;Ludewig B;Löhning M;Bergthaler A
Tissue damage caused by viral hepatitis is a major cause of morbidity and mortality worldwide. Using a mouse model of viral hepatitis, we identified virus-induced early transcriptional changes in the redox pathways in the liver, including downregulation of superoxide dismutase 1 (Sod1). Sod1−/− mice exhibited increased inflammation and aggravated liver damage upon viral infection, which was independent of T and NK cells and could be ameliorated by antioxidant treatment. Type I interferon (IFN-I) led to a downregulation of Sod1 and caused oxidative liver damage in Sod1−/− and wild-type mice. Genetic and pharmacological ablation of the IFN-I signaling pathway protected against virus-induced liver damage. These results delineate IFN-I mediated oxidative stress as a key mediator of virus-induced liver damage and describe a mechanism of innate-immunity-driven pathology, linking IFN-I signaling with antioxidant host defense and infection-associated tissue damage. Viral infection leads to redox dysregulation including the downregulation of SOD1 Sod1 −/− mice exhibit aggravated viral hepatitis, which is rescued by antioxidants IFN-I signaling via STAT1 drives SOD1 downregulation and early liver damage Ablation of IFN-I signaling ameliorates viral hepatitis in Sod1 −/− and WT mice Bergthaler and colleagues show that superoxide dismutase 1 protects the liver from type I interferon-driven oxidative damage in viral hepatitis. Liver damage was mediated by hepatocyte-intrinsic IFNAR1-STAT1 signaling.